Advertisement

Topics

Latest "Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer" News Stories

07:36 EDT 15th October 2018 | BioPortfolio

Here are the most relevant search results for "Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer" found in our extensive news archives from over 250 global news sources.

More Information about Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer for you to read. Along with our medical data and news we also list Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Companies for you to search.

Showing "Amifostine Treating Women With Ovarian Peritoneal Cervical Fallopian" News Articles 1–25 of 8,600+

Monday 15th October 2018

X4 Pharmaceuticals and Collaborators Present Data that WHIM Syndrome is Underdiagnosed and Patients are Impacted by Broad Spectrum of Medical Complications

Three poster presentations showcased at NORD Rare Disease Summit Company continues to support genetic screening program to aid in diagnosis of patients with WHIM syndrome X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 antagonist drugs, today announced that the company and its collaborators have had thr...


Innovus Pharma Receives Approval from Amazon® to Expand its Amazon® Stores to Japan

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced the approval from Amazon...

High Park Company Introduces Comprehensive Portfolio of Adult-Use Cannabis Brands

Company unveils three new brands exclusive to the Canadian adult-use market High Park Holdings Ltd. (“High Park”), a subsidiary of Tilray, Inc. (NASDAQ:TLRY), today unveiled a broad-based portfolio of cannabis brands including three new, original brands exclusive to the Canadian adult-use market: Canaca™, Dubon™ and Yukon Rove. High Park...


NIH Awards Allele with Grant for the Development of Nanoantibody Therapies for Treating Sepsis

The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody (nAb) therapies for the treatment of sepsis. Sepsis and septic shock are among the leading causes of death in intensive care units (ICUs). The global incidence...

Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer

New Pyramid of Sexual Health By Enviromax Helps People Create Balance For Living More Fulfilled Lives

Your Complete Sexual Fulfillment Could Be Only Three Steps Away! FAIRBANKS, Alaska (PRWEB) October 15, 2018 Enviromax presents a new Sexual Health Pyramid for Prostate Cradle customers and people everywhere to learn how to improve physical health, sexual health, and spiritual health! The sexual health pyramid is designed to help people achieve higher levels of fulfillment in their lives. There i...

Support group for women hit by CervicalCheck scandal ‘to fight for accountability’ – Independent.ie

Independent.ieSupport group for women hit by CervicalCheck scandal 'to fight for accountability'Independent.ieA new support group set up, by and for the women hit by the CervicalCheck scandal and their families will campaign for laws enshrining management-level accountability in the public service. Vicky Phelan, Lorraine Walsh and Stephen Teap were among ...Women in cervical cancer scandal sceptic...

C-section rates have nearly doubled since 2000 – Health24

Health24C-section rates have nearly doubled since 2000Health24The number of women delivering babies via cesarean section has nearly doubled worldwide since 2000, to about 21%, new research shows. That's significantly higher than the 10% to 15% considered medically necessary, researchers said.C-Section Births Doubled Globally Since 2000: Lancet StudyThe QuintC-section births surge to 'alarming' rat...

Genentech’s Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment

– Phase III KATHERINE study shows Kadcyla® significantly improved invasive disease-free survival compared to Herceptin® in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment – – Data will be submitted to health authorities around the world, including the U.S. Food and Drug Administration and Eur...

Sunday 14th October 2018

Feminine leadership traits: Nice but expendable frills?

(Frontiers) The first study to examine tradeoffs in masculine versus feminine leadership traits reveals that stereotypically feminine traits -- like being tolerant and cooperative -- are viewed as desirable but ultimately superfluous add-ons. Instead, both men and women believe successful leaders need stereotypically masculine traits such as assertiveness and competence. The finding could help exp...

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $3500

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review, H2 2018SummaryCarcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 pipeline Target constitutes close to 11 molecules. Out of which approximately 8 molecules are develo...

Sugar, a “sweet” tool to understand brain injuries

Australian researchers have developed ground-breaking new technology which could prove crucial in treating brain injuries and have multiple other applications, including testing the success of cancer therapies.

CHA Bio Diostech Co Ltd 085660 Financial and Strategic SWOT Analysis Review [Report Updated: 28092018] Prices from USD $300

SummaryCHA Bio Diostech Co Ltd CHA Biotech is a biotechnology company that offers diverse stem cell banking solutions for future medical use. The company provides cell therapy development, cord blood, and stem cell banking services. It offers stem cell research and development pipelines in the therapeutic areas including agerelated macular degeneration, intermittent caludication, stroke, stargard...

Endometriosis Pipeline Review, H2 2018 [Report Updated: 18092018] Prices from USD $2000

Endometriosis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis Pipeline Review, H2 2018, provides an overview of the Endometriosis Women's Health pipeline landscape.Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus endometrium grows outside uterus endometrial implant....

RTI Surgical Inc RTIX Medical Equipment Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250

SummaryRTI Surgical Inc RTI, formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company's products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such as demineralized bone matrix powder, anterior cervical plate system, cancellous chips, cequence anteri...

Saturday 13th October 2018

When Dr. Betsy Nabel, president of @BrighamWomens and professor at @harvardmed was asked about the idea that there aren’t enough qualified women to join company boards, her response was simple: “Malarkey.” https://buff.ly/2yzgPcp pic.twitter.com/j

When Dr. Betsy Nabel, president of @BrighamWomens and professor at @harvardmed was asked about the idea that there aren’t enough qualified women to join company boards, her response was simple: “Malarkey.” https://buff.ly/2yzgPcp  pic.twitter.com/jEUDcph9Tc

Nanolek Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryNanolek is a drug development company that offers production of importsubstituting and novel pharmaceuticals. The company's product portfolio includes vaccines, drugs for treatment of leukemias, breast cancer, brain cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and other diseases. It also conducts clinical trials on generic, biosimilar and innovative products. Nanolek...

Ritter Pharmaceuticals Inc RTTR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryRitter Pharmaceuticals Inc Ritter is a developer of therapeutic products for gastrointestinal diseases. The company's lead product includes RPG28, which is developed stimulate the growth of lactosemetabolizing bacteria in the colon to assist in digesting process. Its product is under the development for the treatment of lactose intolerance. The company conducts research and development for ...

BioXcel Therapeutics Inc BTAI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryBioXcel Therapeutics Inc BioXcel Therapeutics a subsidiary of BioXcel Corp is a clinical stage biopharmaceutical company focused on novel artificial intelligencebased drug development in the fields of neuroscience and immunooncology. Its pipeline product portfolio includes BXCL501, an adrenergic agent with a sublingual route of administration is used for treating neuropsychiatric and neurod...

Opinion: Are my #breastcancer and I on the wrong side of statistics, or just caught in the confusing and potentially devastating conflict between medical societies about when women should start breast-cancer screening? https://buff.ly/2Ei8Nuw 

Opinion: Are my #breastcancer and I on the wrong side of statistics, or just caught in the confusing and potentially devastating conflict between medical societies about when women should start breast-cancer screening? https://buff.ly/2Ei8Nuw 

Global Ball Sports Protection Products Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Undiagnosed Diseases; TDAP and Pregnancy: It's PodMed Double T! (with audio)

(MedPage Today) -- This week's topics include undiagnosed diseases, sexual assault and mental and physical health in women, timing of TDAP in pregnancy, and statins beyond cardiovascular disease.

Oncolytics Biotech Inc ONC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryOncolytics Biotech Inc Oncolytics is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company's lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of lung, ovarian, colorectal, pancreatic, prostate, breast, head and neck cancers. Reolysin is also undergo...

Global Approach Shoes Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

AdAlta Ltd 1AD Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummaryAdAlta Ltd AdAlta, formerly AdAlta Pty Ltd is a biotechnology company that discovers and develops new class of protein therapeutics for wide range of human diseases. The company's lead ibody candidate, AD114, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. Its ibody products are developed using proprietary technology platform that delivers ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks